Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin [MVAC] versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer.
暂无分享，去创建一个
M. Dimopoulos | A. Bamias | E. Kostouros | C. Papandreou | F. Zagouri | I. Xanthakis | E. Samantas | A. Karadimou | N. Soupos | G. Fountzilas | G. Aravantinos | D. Pectasides | S. Lampaki | G. Lainakis | C. Deliveliotis | C. Hatzimouratidis | C. Konstantinidis